Ünal Egelí

1.8k total citations
124 papers, 1.4k citations indexed

About

Ünal Egelí is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ünal Egelí has authored 124 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 35 papers in Cancer Research and 30 papers in Oncology. Recurrent topics in Ünal Egelí's work include MicroRNA in disease regulation (18 papers), Genomic variations and chromosomal abnormalities (12 papers) and Cancer-related molecular mechanisms research (12 papers). Ünal Egelí is often cited by papers focused on MicroRNA in disease regulation (18 papers), Genomic variations and chromosomal abnormalities (12 papers) and Cancer-related molecular mechanisms research (12 papers). Ünal Egelí collaborates with scholars based in Türkiye, Russia and United States. Ünal Egelí's co-authors include Berrin Tunca, Gülşah Çeçener, Gamze Güney Eskiler, Gülçin Tezcan, Şahsine Tolunay, Tahsin Yakut, Seçil Ak, Ahmet Bekâr, Ömer Yerci and İsmet Taşdelen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Environmental Health Perspectives.

In The Last Decade

Ünal Egelí

124 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ünal Egelí Türkiye 20 759 475 254 241 113 124 1.4k
Berrin Tunca Türkiye 20 719 0.9× 453 1.0× 229 0.9× 171 0.7× 73 0.6× 113 1.3k
Evangelos Kolettas Greece 22 760 1.0× 383 0.8× 309 1.2× 86 0.4× 71 0.6× 51 1.4k
Sandrine Dabernat France 22 1.2k 1.6× 312 0.7× 389 1.5× 223 0.9× 151 1.3× 55 1.7k
Clarissa Ribeiro Reily Rocha Brazil 21 960 1.3× 349 0.7× 293 1.2× 94 0.4× 166 1.5× 35 1.4k
Jung‐Hwa Oh South Korea 21 866 1.1× 243 0.5× 223 0.9× 166 0.7× 96 0.8× 69 1.4k
Peng Bai China 24 972 1.3× 380 0.8× 192 0.8× 92 0.4× 92 0.8× 69 1.5k
Weiwei Li China 21 959 1.3× 380 0.8× 218 0.9× 200 0.8× 135 1.2× 72 1.5k
Aurélie Bedel France 20 888 1.2× 255 0.5× 248 1.0× 155 0.6× 123 1.1× 41 1.3k
Sihan Wu China 18 846 1.1× 676 1.4× 157 0.6× 66 0.3× 88 0.8× 49 1.4k

Countries citing papers authored by Ünal Egelí

Since Specialization
Citations

This map shows the geographic impact of Ünal Egelí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ünal Egelí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ünal Egelí more than expected).

Fields of papers citing papers by Ünal Egelí

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ünal Egelí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ünal Egelí. The network helps show where Ünal Egelí may publish in the future.

Co-authorship network of co-authors of Ünal Egelí

This figure shows the co-authorship network connecting the top 25 collaborators of Ünal Egelí. A scholar is included among the top collaborators of Ünal Egelí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ünal Egelí. Ünal Egelí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egelí, Ünal, et al.. (2025). Effect of pain-related sodium channels SCN9A and SCN10A polymorphisms in migraine chronification. Neurological Research. 47(8). 698–709. 1 indexed citations
2.
3.
4.
Egelí, Ünal, et al.. (2023). The cytotoxic and antitumoral effects of Remdesivir, an antiviral RdRp inhibitor, on different cancer cells in vitro. Molecular & Cellular Toxicology. 20(3). 649–660. 4 indexed citations
5.
6.
Egelí, Ünal, et al.. (2022). An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating. Clinical and Experimental Pharmacology and Physiology. 49(10). 1094–1104. 3 indexed citations
7.
Eskiler, Gamze Güney, et al.. (2021). The Activation of PI3K/AKT/mTOR Signaling Pathway in Response to Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer Cells. SHILAP Revista de lepidopterología. 80(2). 138–144. 1 indexed citations
8.
Çeçener, Gülşah, et al.. (2021). Investigation of VHL gene associated with miR-223 in clear cell renal cell carcinoma. Molecular Biology Reports. 49(3). 2073–2083. 1 indexed citations
9.
Egelí, Ünal, et al.. (2021). The Anticancer Effect of Inula viscosa Methanol Extract by miRNAs’ Re-regulation: An in vitro Study on Human Malignant Melanoma Cells. Nutrition and Cancer. 74(1). 211–224. 10 indexed citations
10.
Eskiler, Gamze Güney, et al.. (2020). Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells. Human & Experimental Toxicology. 40(7). 1122–1129. 4 indexed citations
11.
Eskiler, Gamze Güney, Gülşah Çeçener, Ünal Egelí, & Berrin Tunca. (2020). Talazoparib nanoparticles for overcoming multidrug resistance in triple‐negative breast cancer. Journal of Cellular Physiology. 235(9). 6230–6245. 23 indexed citations
12.
Tezcan, Gülçin, Berrin Tunca, Ahmet Bekâr, et al.. (2019). Oleuropein modulates glioblastoma miRNA pattern different from Olea europaea leaf extract. Human & Experimental Toxicology. 38(9). 1102–1110. 15 indexed citations
13.
Eskiler, Gamze Güney, Gülşah Çeçener, Ünal Egelí, & Berrin Tunca. (2019). Reversal effect of quercetin on talazoparib resistance in BRCA1 mutant triple negative breast cancer. The European Research Journal. 6(1). 19–25. 2 indexed citations
14.
Eskiler, Gamze Güney, et al.. (2019). Synergistic effects of hormone therapy drugs and usnic acid on hormone receptor‐positive breast and prostate cancer cells. Journal of Biochemical and Molecular Toxicology. 33(8). e22338–e22338. 7 indexed citations
15.
Egelí, Ünal, et al.. (2018). The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma. Human & Experimental Toxicology. 38(2). 201–215. 28 indexed citations
16.
Eskiler, Gamze Güney, et al.. (2018). In vitro cytotoxic and antiproliferative effects of usnic acid on hormone‐dependent breast and prostate cancer cells. Journal of Biochemical and Molecular Toxicology. 32(10). e22208–e22208. 19 indexed citations
17.
18.
Ak, Seçil, Gamze Güney Eskiler, Elif Ertürk, et al.. (2016). Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.. PubMed. 17(9). 4241–4246. 23 indexed citations
19.
Eskiler, Gamze Güney, Gülşah Çeçener, Berrin Tunca, & Ünal Egelí. (2016). An in vitro model for the development of acquired tamoxifen resistance. Cell Biology and Toxicology. 32(6). 563–581. 12 indexed citations
20.
Tunca, Berrin, Ünal Egelí, Gülşah Çeçener, et al.. (2012). CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.. PubMed. 98(2). 243–51. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berrin Tunca Breakdown of academic impact, for papers by Evangelos Kolettas Breakdown of academic impact, for papers by Sandrine Dabernat Breakdown of academic impact, for papers by Clarissa Ribeiro Reily Rocha Breakdown of academic impact, for papers by Jung‐Hwa Oh Breakdown of academic impact, for papers by Peng Bai Breakdown of academic impact, for papers by Weiwei Li Breakdown of academic impact, for papers by Aurélie Bedel Breakdown of academic impact, for papers by Sihan Wu
Rankless by CCL
2026